Multus is a biotechnology company helping create lab-grown meat, by developing an animal-free alternative to blood serum used in these ‘clean’ meats founded by four Imperial students: Reka Tron from Hungary, Cai Linton from the UK, Kevin Pan from Austria and Brandon Ma from South Korea. 

Multus won a highly prestigious European Innovation Council grant worth €2.5m in June 2022, which has been followed by successfully raising £7.9m of investment in early 2023. The company has now opened the world’s first pilot manufacturing plant, greatly increasing the growth potential for the global cultivated meat market.

The new facility is the first of its kind to achieve FSSC 22000 certification, establishing Multus as a ‘food-safe’ global scaling partner. It combines the quality requirements for cell culturing with the food safety requirements of the meat industry, and is enabling Multus to support cultivated meat companies around the world in producing up to an estimated 500 tonnes of meat per year.